Committee members largely blamed the other party’s health care policies for driving U.S. health care prices to levels ...
The administration had alleged that Gilead ignored the contributions by CDC scientists, exaggerated its own role in ...
The Food and Drug Administration on Tuesday announced efforts to make clinical trials more efficient, starting by reviewing ...
STAT closely follows AP style and has used “health care” since its founding in 2015. Now, we have to decide whether to adopt ...
For the first time, FDA regulators will be able to see what’s happening in a clinical trial, looking at endpoints in the ...
The charges against Morens come after Congressional probes related to the origins of the virus that causes Covid-19.
The Supreme Court on Wednesday will hear oral arguments about a simmering controversy over so-called skinny labels, with implications for the availability of generics.
Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...
Google's clinical director Megan Bell Jones on how the company is addressing concerns over mental health impacts of its AI ...
Pharmalittle: We’re reading about warnings over Trump’s MFN plan, Purdue Pharma sentencing, and more
The Novartis CEO warned that Trump's drug pricing policy poses a “very difficult situation” and the reality will soon catch ...
Failing to adopt a more inclusive concept of brain health represents a massive loss of human potential,” write Husseini K.
Eli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and more biotech news today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results